These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 14695825)

  • 81. Crystal structure of the novel aspartic proteinase zymogen proplasmepsin II from plasmodium falciparum.
    Bernstein NK; Cherney MM; Loetscher H; Ridley RG; James MN
    Nat Struct Biol; 1999 Jan; 6(1):32-7. PubMed ID: 9886289
    [TBL] [Abstract][Full Text] [Related]  

  • 82. New class of small nonpeptidyl compounds blocks Plasmodium falciparum development in vitro by inhibiting plasmepsins.
    Jiang S; Prigge ST; Wei L; Gao Ye ; Hudson TH; Gerena L; Dame JB; Kyle DE
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2577-84. PubMed ID: 11502532
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Fighting malaria: structure-guided discovery of nonpeptidomimetic plasmepsin inhibitors.
    Huizing AP; Mondal M; Hirsch AK
    J Med Chem; 2015 Jul; 58(13):5151-63. PubMed ID: 25719272
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Computational prediction of structure, substrate binding mode, mechanism, and rate for a malaria protease with a novel type of active site.
    Bjelic S; Aqvist J
    Biochemistry; 2004 Nov; 43(46):14521-8. PubMed ID: 15544322
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Flap flexibility amongst plasmepsins I, II, III, IV, and V: Sequence, structural, and molecular dynamics analyses.
    McGillewie L; Soliman ME
    Proteins; 2015 Sep; 83(9):1693-705. PubMed ID: 26146842
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Design, synthesis, and X-ray structure of potent memapsin 2 (beta-secretase) inhibitors with isophthalamide derivatives as the P2-P3-ligands.
    Ghosh AK; Kumaragurubaran N; Hong L; Kulkarni SS; Xu X; Chang W; Weerasena V; Turner R; Koelsch G; Bilcer G; Tang J
    J Med Chem; 2007 May; 50(10):2399-407. PubMed ID: 17432843
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Effects on growth, hemoglobin metabolism and paralogous gene expression resulting from disruption of genes encoding the digestive vacuole plasmepsins of Plasmodium falciparum.
    Bonilla JA; Moura PA; Bonilla TD; Yowell CA; Fidock DA; Dame JB
    Int J Parasitol; 2007 Mar; 37(3-4):317-27. PubMed ID: 17207486
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Is histoaspartic protease a serine protease with a pepsin-like fold?
    Andreeva N; Bogdanovich P; Kashparov I; Popov M; Stengach M
    Proteins; 2004 May; 55(3):705-10. PubMed ID: 15103632
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Potent inhibitors of malarial aspartic proteases, the plasmepsins, by hydroformylation of substituted 7-azanorbornenes.
    Aureggi V; Ehmke V; Wieland J; Schweizer WB; Bernet B; Bur D; Meyer S; Rottmann M; Freymond C; Brun R; Breit B; Diederich F
    Chemistry; 2013 Jan; 19(1):155-64. PubMed ID: 23161835
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Structural basis for plasmepsin V inhibition that blocks export of malaria proteins to human erythrocytes.
    Hodder AN; Sleebs BE; Czabotar PE; Gazdik M; Xu Y; O'Neill MT; Lopaticki S; Nebl T; Triglia T; Smith BJ; Lowes K; Boddey JA; Cowman AF
    Nat Struct Mol Biol; 2015 Aug; 22(8):590-6. PubMed ID: 26214367
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Structure of the aspartic protease plasmepsin 4 from the malarial parasite Plasmodium malariae bound to an allophenylnorstatine-based inhibitor.
    Clemente JC; Govindasamy L; Madabushi A; Fisher SZ; Moose RE; Yowell CA; Hidaka K; Kimura T; Hayashi Y; Kiso Y; Agbandje-McKenna M; Dame JB; Dunn BM; McKenna R
    Acta Crystallogr D Biol Crystallogr; 2006 Mar; 62(Pt 3):246-52. PubMed ID: 16510971
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Discovery of a rhodanine class of compounds as inhibitors of Plasmodium falciparum enoyl-acyl carrier protein reductase.
    Kumar G; Parasuraman P; Sharma SK; Banerjee T; Karmodiya K; Surolia N; Surolia A
    J Med Chem; 2007 May; 50(11):2665-75. PubMed ID: 17477517
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Structural and active site analysis of plasmepsins of Plasmodium falciparum: potential anti-malarial targets.
    Bhargavi R; Sastry GM; Murty US; Sastry GN
    Int J Biol Macromol; 2005 Oct; 37(1-2):73-84. PubMed ID: 16242183
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Calculating proton uptake/release and binding free energy taking into account ionization and conformation changes induced by protein-inhibitor association: application to plasmepsin, cathepsin D and endothiapepsin-pepstatin complexes.
    Alexov E
    Proteins; 2004 Aug; 56(3):572-84. PubMed ID: 15229889
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Anti-plasmodial activity of Ailanthus excelsa.
    Dell'Agli M; Galli GV; Parapini S; Basilico N; Taramelli D; Said A; Rashed K; Bosisio E
    Fitoterapia; 2008 Feb; 79(2):112-6. PubMed ID: 18166279
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Structures of plasmepsin II from Plasmodium falciparum in complex with two hydroxyethylamine-based inhibitors.
    Recacha R; Leitans J; Akopjana I; Aprupe L; Trapencieris P; Jaudzems K; Jirgensons A; Tars K
    Acta Crystallogr F Struct Biol Commun; 2015 Dec; 71(Pt 12):1531-9. PubMed ID: 26625296
    [TBL] [Abstract][Full Text] [Related]  

  • 97. New paradigm of an old target: an update on structural biology and current progress in drug design towards plasmepsin II.
    Dan N; Bhakat S
    Eur J Med Chem; 2015 May; 95():324-48. PubMed ID: 25827401
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Exploring dual inhibitory role of febrifugine analogues against Plasmodium utilizing structure-based virtual screening and molecular dynamic simulation.
    Pandey RK; Narula A; Naskar M; Srivastava S; Verma P; Malik R; Shah P; Prajapati VK
    J Biomol Struct Dyn; 2017 Mar; 35(4):791-804. PubMed ID: 26984239
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Solid-phase library synthesis of reversed-statine type inhibitors of the malarial aspartyl proteases plasmepsin I and II.
    Dahlgren A; Kvarnström I; Vrang L; Hamelink E; Hallberg A; Rosenquist A; Samuelsson B
    Bioorg Med Chem; 2003 Mar; 11(6):827-41. PubMed ID: 12614868
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The activity and inhibition of the food vacuole plasmepsin from the rodent malaria parasite Plasmodium chabaudi.
    Martins TM; Domingos A; Berry C; Wyatt DM
    Acta Trop; 2006 Feb; 97(2):212-8. PubMed ID: 16329985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.